If you are trying to blame the volume on external forces thats ok but if you want ideas and some one to follow that will make you money mark this person.. I do and when he gives an idea,, I buy and he alway's makes me money.. His stocks have DD and depth in thier markets on the bid side.. They are true Value Micro Caps..
Knowledge is King Monday, March 11, 2013 12:40:53 PM
Re: None Post # of 8715
Took a flyer on IEVM($.04); drug-resistant bacteria eliminated by IEVM's Excelyte product. I'm seeing this health-care issue mentioned frequently in the media these days....
Integrated Environmental Technologies, Ltd. Announces That Excelyte(R) is
Effective Against Drug Resistant Bacteria Contaminating Healthcare
Facilities
Excelyte(R) Eliminates CRE Bacteria Recently Cited in Centers for Disease
Control and Prevention Health Advisory
LITTLE RIVER, S.C., March 11, 2013 (GLOBE NEWSWIRE) -- Integrated
Environmental Technologies, Ltd. ("IET" or the "Company") (OTC Bulletin
Board:IEVM), today announced that carbapenem-resistant Enterobacteriaceae
(CRE), recently cited in a Centers for Disease Control and Prevention (the
"CDC") Health Advisory, is eliminated by Excelyte(R). Specifically,
Excelyte(R) eliminates the two most common types of CRE: Klebsiella
pneumonia carbapenemase (KPC) and New Delhi Metallo-Beta Lactamase (NDM).
KPC was found in the National Institutes of Health Clinical Center last
summer, killing seven people. NDM has accounted for 29 of the 37 cases of
rare forms of CRE that have been reported since 2010, of which 15 have been
reported since July 2012. This increase highlights the need for healthcare
providers to act aggressively to prevent the emergence and spread of these
unusual CRE bacteria.
CRE infections most commonly occur in healthcare settings among patients who
are receiving treatment for other conditions. Patients whose care requires
devices like ventilators, urinary catheters or intravenous catheters, and
patients who are taking long courses of certain antibiotics, are most at
risk for CRE infections. CRE infections have a mortality rate of up to 40
percent. Since CRE bacteria such as KPC and NDM are highly resistant to
multiple drugs, preventing the spread of these bacteria has become the focal
point for healthcare providers.
The Company's testing of Excelyte(R) against KPC and NDM was conducted by an
independent U.S. Environmental Protection Agency (the "EPA") approved
laboratory. The CDC provided the carbapenem resistant strain of Klebsiella
pneumonia NDM to the laboratory. This strain is resistant to penicillin,
gentamicin, ceftazidime and other antibiotics. The test results show that
Excelyte(R), diluted 50%, is effective in killing this strain. These test
results have been submitted to the EPA and the Company is awaiting approval
to add them to its EPA master label claims.
David LaVance, Chairman, President and Chief Executive Officer of the
Company, commented "CRE infections are becoming a major problem for
healthcare facilities. Since CRE are drug resistant, the only way to
eliminate the problem is through prevention. Healthcare providers need to be
able to treat their facilities on a regular basis to prevent the spread of
bacteria such as CRE and C. difficile spores. The efficacy and non-toxic
nature of Excelyte(R) make it an ideal product for a healthcare provider
since it can be applied in spray format and can completely cover a
facility."
Healthcare providers interested in obtaining information from IET regarding
Excelyte(R) should contact Tim Shields at 843-390-2500 x203 or by sending an
email to healthcareinfo@ietltd.net.
About Integrated Environmental Technologies, Ltd.
Integrated Environmental Technologies, Ltd., is a publicly-traded company
that operates through its wholly-owned operating subsidiary, I.E.T., Inc.
The Company sells a disinfecting solution under the EcaFlo(TM) and
Excelyte(R) brand names and sells a cleaning solution under the Catholyte
Zero(TM) brand name. Both solutions are produced by the Company's
proprietary EcaFlo(TM) equipment which utilizes an electrolytic process
known as electrochemical activation to reliably produce environmentally
responsible solutions for cleaning, sanitizing and disinfecting. EcaFlo(TM)
Anolyte and Excelyte(R) solutions are EPA-registered hard surface
disinfectants and sanitizers approved for hospital-level use and are also
approved for use as a biocide in oil and gas drilling. The products can be
used safely anywhere there is a need to control pathogens, bacteria,
viruses, and germs. Catholyte Zero(TM) solutions are an environmentally
friendly cleanser and degreaser for janitorial, sanitation and food
processing uses. The Company is currently focused on selling its products to
dairy farmers, oil and gas production companies and the healthcare
facilities. To learn more about Integrated Environmental Technologies, Ltd.
and I.E.T., Inc., please visit our websites at www.ietltd.net (investor
relations) and www.ietecaflo.com (product information).
Forward-Looking Statements
Statements about the Company's future expectations and all other statements
in this press release other than historical facts are forward-looking
statements. Such statements are subject to certain risks, trends and
uncertainties that could cause actual results to differ materially from
expected results. Among these risks, trends and uncertainties are economic
conditions both generally and within the industries in which the company may
participate; competition within the Company's chosen industries, including
competition from much larger competitors; technological advances; available
capital; regulatory approval; and failure by the Company to successfully
develop or acquire products and form new business relationships. Since these
statements involve risks and uncertainties and are subject to change at any
time, the Company's actual results could differ materially from expected
results.
CONTACT: Integrated Environmental Technologies, Ltd.
Thomas S. Gifford
Executive Vice President and Chief Financial Officer
Tel.: (732) 282-1055
Market Data 
Markets 
AI
